Breast Cancer Awareness Month: Shining a Light on Early Detection
Introduction Every year, countless lives are touched by breast cancer. The cornerstone of battling this formidable foe is early detection.
Introduction Every year, countless lives are touched by breast cancer. The cornerstone of battling this formidable foe is early detection.
Epigenetics, a captivating realm of genetics, not only shapes our understanding of aging and cancer but also unravels the mysteries
HKG Epitherapeutics Ltd receives CLIA certification, a testament to its dedication to excellence in clinical laboratory testing. Discover the impact
Discover the groundbreaking high-throughput test developed by HKG Epitherapeutics and partners for the early detection of Hepatocellular Carcinoma. Utilizing distinctive
The concept of “getting old together” takes on a new meaning with the discovery of epigenetic age. This reliable parameter
CELL FREE TUMOR- DERIVED DNA IN PLASMA It is widely established by now that tumor DNA is shed into the
Colorectal cancer is a common and dangerous type of cancer. It is the third most common cancer worldwide, based on
“Alcohol Use Disorder: Forms and Consequences” Alcohol use disorder, also known as alcohol dependence disorder, is a medical condition in
Hong Kong, January 12, 2022 The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to
Methylation, a chemical process involving the addition of methyl groups to particular DNA segments, serves as a key mechanism in
EpiMedTechGlobal (EMTG)
60 Paya Lebar Road,
#08-06 Paya Lebar Square
Singapore 409051
Honk Kong Lab
Unit 313-315, 3/F Biotech Centre 2
11 Science Park West Avenue
Hong Kong Science Park
US Epitherapeutics
1829 Reisterstown Rd, Suite: 350
Baltimore, MD 21208
+1 (443) 256 5179
MTL Epitherapeutics
600 – 2000 AV McGill College Montreal, QC CA H3A3H3
+1 (514) 448 2185
Shenzhen Lab
Zone E, Floor 4, Building E, Gangzhilong Business Center,
Qinglong Road, Longhua District, Shenzhen
Hong Kong: +(852) 60725262 USA: +1 (443) 256 5179 Canada: +1 (514) 448 2185
Founded in 2016 by Prof. Moshe Szyf, a global pioneer in the dynamic and rapidly evolving field of epigenetics, EpiMedTechGlobal (EMTG) stands as a force driving innovation. Officially headquartered in Singapore, our organization directs a state-of-the-art research and diagnostic lab located in Hong Kong, which serves as the epicenter of our groundbreaking endeavors. Here, our dedicated scientists are committed to driving innovation in epigenetics and the early detection of diseases. At EMTG, it’s not just about detecting diseases; it’s about unlocking and offering solutions that promote longevity through the hidden stories in our DNA.